abstract |
The present invention is an agent that inhibits the activity of at least one gene selected from the group consisting of HIC1, FOXS1, CREB5, IRF7, POU2F2, STAT4, and TCF4, and / or selected from the group consisting of MAF, MEOX2, and SIX2. It relates to a therapeutic compound comprising an agent that enhances the activity of at least one gene that is produced. [Selection figure] None |